Literature DB >> 25361207

Systems analysis reveals down-regulation of a network of pro-survival miRNAs drives the apoptotic response in dilated cardiomyopathy.

Ruth Isserlin1, Daniele Merico, Dingyan Wang, Dajana Vuckovic, Nicolas Bousette, Anthony O Gramolini, Gary D Bader, Andrew Emili.   

Abstract

Apoptosis is a hallmark of multiple etiologies of heart failure, including dilated cardiomyopathy. Since microRNAs are master regulators of cardiac development and key effectors of intracellular signaling, they represent novel candidates for understanding the mechanisms driving the increased dysfunction and loss of cardiomyocytes during cardiovascular disease progression. To determine the role of cardiac miRNAs in the apoptotic response, we used microarray technology to monitor miRNA levels in a validated murine phospholambam mutant model of dilated cardiomyopathy. 24 miRNAs were found to be differentially expressed, most of which have not been previously linked to dilated cardiomyopathy. We showed that individual silencing of 7 out of 8 significantly down-regulated miRNAs (mir-1, -29c, -30c, -30d, -149, -486, -499) led to a strong apoptotic phenotype in cell culture, suggesting they repress pro-apoptotic factors. To identify putative miRNA targets most likely relevant to cell death, we computationally integrated transcriptomic, proteomic and functional annotation data. We showed the dependency of prioritized target abundance on miRNA expression using RNA interference and quantitative mass spectrometry. We concluded that down regulation of key pro-survival miRNAs causes up-regulation of apoptotic signaling effectors that contribute to cardiac cell loss, potentially leading to system decompensation and heart failure.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25361207      PMCID: PMC4856157          DOI: 10.1039/c4mb00265b

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  86 in total

Review 1.  Expression and function of microRNAs in heart disease.

Authors:  Sadakatsu Ikeda; William T Pu
Journal:  Curr Drug Targets       Date:  2010-08       Impact factor: 3.465

2.  miR-221/222 suppression protects against endoplasmic reticulum stress-induced apoptosis via p27(Kip1)- and MEK/ERK-mediated cell cycle regulation.

Authors:  Rongyang Dai; Juan Li; Youping Liu; Dongmei Yan; Shaokun Chen; Chunyan Duan; Xiaoyan Liu; Tao He; Hong Li
Journal:  Biol Chem       Date:  2010-07       Impact factor: 3.915

Review 3.  MicroRNAs in cardiac remodeling and disease.

Authors:  Zhan-Peng Huang; Ronald L Neppl; Da-Zhi Wang
Journal:  J Cardiovasc Transl Res       Date:  2010-02-17       Impact factor: 4.132

Review 4.  MicroRNAs in cardiac apoptosis.

Authors:  Peifeng Li
Journal:  J Cardiovasc Transl Res       Date:  2010-03-19       Impact factor: 4.132

Review 5.  MicroRNAs in ovarian cancer biology and therapy resistance.

Authors:  Marijn T M van Jaarsveld; Jozien Helleman; Els M J J Berns; Erik A C Wiemer
Journal:  Int J Biochem Cell Biol       Date:  2010-01-18       Impact factor: 5.085

6.  miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Authors:  Michela Garofalo; Gianpiero Di Leva; Giulia Romano; Gerard Nuovo; Sung-Suk Suh; Apollinaire Ngankeu; Cristian Taccioli; Flavia Pichiorri; Hansjuerg Alder; Paola Secchiero; Pierluigi Gasparini; Arianna Gonelli; Stefan Costinean; Mario Acunzo; Gerolama Condorelli; Carlo Maria Croce
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

7.  Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps.

Authors:  Ruth Isserlin; Daniele Merico; Rasoul Alikhani-Koupaei; Anthony Gramolini; Gary D Bader; Andrew Emili
Journal:  Proteomics       Date:  2010-03       Impact factor: 3.984

8.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

9.  MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.

Authors:  Scot J Matkovich; Wei Wang; Yizheng Tu; William H Eschenbacher; Lisa E Dorn; Gianluigi Condorelli; Abhinav Diwan; Jeanne M Nerbonne; Gerald W Dorn
Journal:  Circ Res       Date:  2009-11-05       Impact factor: 17.367

10.  KEGG for representation and analysis of molecular networks involving diseases and drugs.

Authors:  Minoru Kanehisa; Susumu Goto; Miho Furumichi; Mao Tanabe; Mika Hirakawa
Journal:  Nucleic Acids Res       Date:  2009-10-30       Impact factor: 16.971

View more
  15 in total

Review 1.  Resuscitation of a dead cardiomyocyte.

Authors:  George H Kunkel; Pankaj Chaturvedi; Suresh C Tyagi
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

2.  Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy.

Authors:  Uros Kuzmanov; Hongbo Guo; Diana Buchsbaum; Jake Cosme; Cynthia Abbasi; Ruth Isserlin; Parveen Sharma; Anthony O Gramolini; Andrew Emili
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-14       Impact factor: 11.205

3.  miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy.

Authors:  Satish K Raut; Gurinder B Singh; Bhawna Rastogi; Uma Nahar Saikia; Anupam Mittal; Nilambra Dogra; Sandeep Singh; Rishikesh Prasad; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2016-05-25       Impact factor: 3.396

Review 4.  Systems biology in cardiovascular disease: a multiomics approach.

Authors:  Abhishek Joshi; Marieke Rienks; Konstantinos Theofilatos; Manuel Mayr
Journal:  Nat Rev Cardiol       Date:  2020-12-18       Impact factor: 32.419

Review 5.  A meta-analysis of microRNA expression profiling studies in heart failure.

Authors:  Nasrin Zare; Alieh Gholaminejad; Nasim Dana; Davood Shafie; Arya Mani; Shaghayegh Haghjooy Javanmard
Journal:  Heart Fail Rev       Date:  2021-01-14       Impact factor: 4.214

6.  Analyzing gene expression profiles in dilated cardiomyopathy via bioinformatics methods.

Authors:  Liming Wang; L Zhu; R Luan; L Wang; J Fu; X Wang; L Sui
Journal:  Braz J Med Biol Res       Date:  2016-10-10       Impact factor: 2.590

Review 7.  Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides.

Authors:  Nilanjan Ghosh; Rajesh Katare
Journal:  Cardiovasc Diabetol       Date:  2018-03-22       Impact factor: 9.951

8.  SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition.

Authors:  Zhuqing Jia; Jiaji Wang; Qiong Shi; Siyu Liu; Weiping Wang; Yuyao Tian; Qin Lu; Ping Chen; Kangtao Ma; Chunyan Zhou
Journal:  Apoptosis       Date:  2016-02       Impact factor: 4.677

9.  Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy.

Authors:  Meng Jiao; Hong-Zhao You; Xin-Ying Yang; Hui Yuan; Yu-Lin Li; Wen-Xian Liu; Mei Jin; Jie Du
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

10.  Expression Levels of MicroRNA-146b and Anti-Cardiac Troponin I in Serum of Children with Viral Myocarditis and Their Clinical Significance.

Authors:  Min Yan; Jing Wang; Suyun Wang; Yang Zhang; Ling Liu; Hua Zhao
Journal:  Iran J Public Health       Date:  2021-03       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.